3rd Quarter - Report

PUBLIC CITIZEN for PUBLIC CITIZEN

Firm
Client
Income
—
Expenses
$70,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

11 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

NAFTA renegotiation, NAFTA replacement

LobbyistCovered position, as disclosed
LORI WALLACH —

Contacted: HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); U.S. Trade Representative (USTR); SENATE

Financial Institutions/Investments/Securities FIN

Environmental, Social,and Governance (ESG) disclosure issues

LobbyistCovered position, as disclosed
LISA JEAN GILBERT —

Contacted: Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE

Civil Rights/Civil Liberties CIV

FAIR Act (HR 1423)-Forced Arbitration Injustice Repeal Act

LobbyistCovered position, as disclosed
LISA JEAN GILBERT —
REMINGTON GREGG —

Contacted: Securities & Exchange Commission (SEC); SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1423 (116th)

Banking BAN

Executive compensation reform, Securities reform bills, HR 2515-Whistleblower Protection Reform act of 2019, HR 3885 Wall Street Banker Accountability for Misconduct Act of 2019, S 2155-Genetic Information Privacy Act of 2019, S 2268- Stop subsidizing Multimillion dollar corporate bonuses Act, Volcker rule-Dodd Frank Sec 619, Whistleblower reform, Glass-Steagall reform, Environmental, Social and Governance (ESG) disclosures,

LobbyistCovered position, as disclosed
LISA JEAN GILBERT —
BARTLETT NAYLOR —

Contacted: HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); U.S. Trade Representative (USTR); SENATE

Bills named: H.R. 2515 (116th), H.R. 3885 (116th)

Budget/Appropriations BUD

Clean budget free from poison pill riders, FY20 Appropriations

LobbyistCovered position, as disclosed
LISA JEAN GILBERT —

Contacted: Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE

Government Issues GOV

Presidential Appointee Accountability Act, HR 1/S 949-For the People Act, HR 599-Revolving door proposal, Democracy for all amendment, S 1762-Foreign Agents Registration Act (FARA),HR 745-Strengthen Office of Government ethics, Political Intelligence Transparency Act, Anti-Corruption and Public Integrity Act, National Emergencies Act, Election security, Rule of Law Legislation, Disclosure of Political Spending, Secure our Elections Act/Financial Services and General Government (FSGG) election security, Freedom of Information Act improvements, S 2220-Open and Responsive Government Act and other FOIA reform,

LobbyistCovered position, as disclosed
LISA JEAN GILBERT —
SUSAN ELAINE HARLEY —
CRAIG HOLMAN —

Contacted: U.S. Trade Representative (USTR); Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 745 (116th), H.R. 599 (116th), H.R. 1 (116th)

Consumer Issues/Safety/Products CSP

S. 1419, S-1420-Regulatory reform, Reauthorization of the SBA Act of 2019, Support Privacy Legislation, FAIR Act, Regulatory Policy issues-administrative law, Discussion on Section 6(b)

LobbyistCovered position, as disclosed
LISA JEAN GILBERT —
REMINGTON GREGG —
MATT KENT —
AMIT NARANG —
EMILY PETERSON CASSIN —

Contacted: SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC)

Bills named: S. 1419 (116th)

Pharmacy PHA

HR 1046, S 377-Medicare Negotiation and Competitive Licensing Act, S 1987-End Price Gouging for Medications act, HR 3199-TERM Act, S 1895-Lower Health Care Costs Act, S 1209-(REMEDY act), S 1416-Affordable Prescriptions for Patients Act, HR 2374, S 1224-Stop STALLING Act, HR 3379-PRICED Act, HR 2296, S 1391-(FAIR Drug Pricing Act), drug pricing, HR 2296-METRIC Act, S 2004-Emergency Access to Insulin Act, S 2387-We protect American Investments in Drugs Act (We PAID Act), S 2199-Insulin Price Reduction Act, S 977-Transparent Drug Prices Act, S 378-Stop Price Gouging Act, S 340-CREATES Act, HR 3- Patient Advocacy Transparency Act,

LobbyistCovered position, as disclosed
STEVEN KNIEVEL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Securities & Exchange Commission (SEC); U.S. Trade Representative (USTR)

Bills named: H.R. 2374 (116th), H.R. 2296 (116th), H.R. 3199 (116th), H.R. 3 (116th), H.R. 3379 (116th), H.R. 1046 (116th)

Labor Issues/Antitrust/Workplace LBR

Corporate Concentration and Non-Competes, Clayton and Sherman Act reforms, Heat Protections, Financial whistleblower protections, HR 3668-Asuncion Valdivia Heat Illness and Fatality Prevention Act of 2019, National Defense Authorization Act-Military whistleblower protections, anti-trust reform

LobbyistCovered position, as disclosed
SHANNA DEVINE —
LISA JEAN GILBERT —
JASON ALEXANDER HARMAN —

Contacted: Securities & Exchange Commission (SEC); SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Bills named: H.R. 3668 (116th)

Taxation/Internal Revenue Code TAX

Support Bright Lines Project legislation, Estate Tax and other progressive tax reforms, Wall Street Sales tax/financial transactions tax, tax reform generally, For the 99.8% Act

LobbyistCovered position, as disclosed
SUSAN ELAINE HARLEY —
EMILY PETERSON CASSIN —

Contacted: SENATE; Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Health Issues HCR

Medicare for All

LobbyistCovered position, as disclosed
LISA JEAN GILBERT —
EAGAN KEMP —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE; Securities & Exchange Commission (SEC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.